Incyte to Present at Upcoming Investor Conferences

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of June:

  • William Blair 41st Annual Growth Stock Conference (Virtual) on Thursday, June 3, 2021 at 1:00 pm (EDT)
  • BioPharma Sustainability Roundtable’s CEO Investor Forum on Monday, June 7, 2021 at 1:35 pm (EDT)
  • Goldman Sachs 42nd Annual Global Healthcare Conference (Virtual) on Tuesday, June 8, 2021 at 8:00 am (EDT)
  • Guggenheim’s “Biopharma’s Next Decade: Views from the Top on Global Strategy and Innovation” Series on Monday, June 28, 2021 at 11:00 am (EDT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  270.15
+4.33 (1.63%)
AAPL  299.67
+4.87 (1.65%)
AMD  450.75
+2.46 (0.55%)
BAC  50.36
-0.42 (-0.83%)
GOOG  397.50
+13.68 (3.56%)
META  615.27
+12.27 (2.03%)
MSFT  405.75
-2.02 (-0.50%)
NVDA  226.82
+6.04 (2.74%)
ORCL  188.59
+1.75 (0.94%)
TSLA  449.77
+16.32 (3.76%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.